Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03753243
Title Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Mark Garzotto, MD
Indications

prostate adenocarcinoma

Therapies

Enzalutamide + Pembrolizumab

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
VA Portland Healthcare System Recruiting Portland Oregon 97239 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field